关于公司
- 法定名称: Hybio Pharmaceutical Co.,Ltd
- 注册国家: China
- 地址: Hybio Innovation Industry Building, , No. 7, Guansheng 4th Rd, , Guanlan High-tech Park,, Shenzhen
- 员工人数: 500 - 999
描述:
Founded in 1998, Hybio is a high-tech enterprise specializing in R&D and manufacturing of diverse peptide products, growing into a leading peptide pharmaceutical company and the first of its kind to go public in China (2011, stock code 300199). The company offers a full range of peptide products (API and finished dosage forms) and services (CRO and CDMO), with peptide finished products mainly sold domestically and peptide APIs supplied worldwide, and its Shenzhen headquarters has passed local and national NMPA GMP inspections more than 90 times.
业务活动
原料药 (API)
制造商原料药生产商
成品制剂
制造商原料药生产商
原研原料药
制造商原料药生产商
销售市场
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
主要产品/服务
我们的产品与服务
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
FDA
GMP
Proofs
CPHI Americas 2026
06/2026 – 06/2026
CPHI Americas 2026
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论